Keyphrases
Receptor Tyrosine Kinase
100%
Hematological Malignancies
100%
Molecular Regulation
100%
Tyrosine Kinase Activity
50%
Erythroleukemia
33%
Dysregulation
16%
Non-overlapping
16%
Acute Myeloid Leukemia
16%
Fibroblast Growth Factor 1 (FGF1)
16%
Leukemia
16%
Spleen
16%
Kit Receptor Tyrosine Kinase
16%
Human Leukemia
16%
Truncated Forms
16%
Chromosomal Translocation
16%
Ron Receptor
16%
Chronic Myeloid Leukemia
16%
Hematopoietic Cells
16%
Friend Virus
16%
Mast Cell Leukemia
16%
Malignant Hematopoiesis
16%
Normal Hematopoiesis
16%
FMS-like Tyrosine Kinase 3 (FLT3)
16%
Pharmacology, Toxicology and Pharmaceutical Science
Protein Tyrosine Kinase
100%
Hematopoietic System Malignancy
100%
Receptor
50%
Leukemia
25%
Erythroleukemia
25%
Platelet Derived Growth Factor
12%
Acute Myeloid Leukemia
12%
Chronic Myeloid Leukemia
12%
Friend Murine Leukemia Virus
12%
Chromosome Translocation
12%
Fibroblast Growth Factor 1
12%
Biochemistry, Genetics and Molecular Biology
Receptor Tyrosine Kinase
100%
Target Cell
12%
Animal Model
12%
Myeloid
12%
Mast Cell
12%
Tyrosine Kinase
12%
Platelet-Derived Growth Factor
12%
Chromosomal Translocation
12%
Hematopoiesis
12%
Friend Murine Leukemia Virus
12%